The Coalition for Healthcare Communication (CHC) -- comprised of major advertising, marketing and PR organizations, including the American Association of Advertising Agencies, the Association of National Advertisers, and the Public Relations Society of America -- filed a Citizen Petition with the Food and Drug Administration today asking the FDA to formulate new rules governing consumer advertising of prescription drugs.

The proposal calls for the elimination of specific risk information in print and broadcast DTC (direct to consumer) advertising.

Read today's post to Pharma Marketing Blog, to learn more about the CHC proposal and whether anyone -- in Congress or the FDA, that is -- will salute this flag.

Survey About CHC's Petition to FDA on DTC and Risk Communication

I put together a quick and easy survey that asks two questions regarding the CHC's proposal:

1. Does it have merit?
2. How likely is the FDA to adopt the suggestions?

You can find this survey at: http://www.surveymonkey.com/s.asp?u=584891966082

As usual, you can be anonymous and you will be able to see de-identified results (no open-ended responses) immediately after taking the survey.

Remember, the devil is in the details and your comments are welcome (the survey includes a comment box).

Take the Survey Now!